EMIS.L लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Oct 2023 @ 20:59):

Stats
आज की मात्रा	646 116
औसत मात्रा	929 131
बाजार मूल्य	1.23B
EPS	£0 ( 2023-09-06 )
अगली कमाई की तारीख	( £0 ) 2024-05-23
Last Dividend	£21.10 ( 2023-06-15 )
Next Dividend	£0 ( N/A )
P/E	40.89
ATR14	£9.82 (0.51%)

मात्रा सहसंबंध

लंबा: 0.10 (neutral)

छोटा: 0.14 (neutral)

Signal:(63.039) Neutral

EMIS Group PLC सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

EMIS Group PLC सहसंबंध - मुद्रा/वस्त्र

0.79
( moderate )

0.59
( weak )

0.52
( weak )

0.42
( neutral )

-0.76
( moderate negative )

EMIS Group PLC वित्तीय

Annual	2022
राजस्व:	£175.37M
सकल लाभ:	£162.47M (92.64 %)
EPS:	£0.530

FY	2022
राजस्व:	£175.37M
सकल लाभ:	£162.47M (92.64 %)
EPS:	£0.530

FY	2021
राजस्व:	£168.23M
सकल लाभ:	£151.97M (90.34 %)
EPS:	£0.462

FY	2020
राजस्व:	£159.45M
सकल लाभ:	£139.12M (87.25 %)
EPS:	£0.481

Financial Reports:

No articles found.

EMIS Group PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£17.60 (N/A)	£0 (N/A)	£21.10 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

EMIS Group PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.22 - Stable (4.47%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£5.60	2010-09-22
Last Dividend	£21.10	2023-06-15
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	27	--
Total Paid Out	£308.10	--
Avg. Dividend % Per Year	1.42%	--
Score	4.57	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.22
Div. Directional Score	9.09	--

Next Divdend (Est)
(2024-10-10)

£0 Estimate 3.68 %

Dividend Stability

0.29 Very Poor

Dividend Score

4.57

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2010	£0	0.00%
2011	£0	0.00%
2012	£0	0.00%
2013	£0	0.00%
2014	£0	0.00%
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£27.10	3.18%
2019	£29.80	3.24%
2020	£31.60	2.82%
2021	£33.60	3.03%
2022	£35.20	2.65%
2023	£21.10	1.13%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RIO.L	Dividend King	2023-08-10	Semi-Annually	32	3.46%
HBR.L	Dividend Knight	2023-09-07	Semi-Annually	3	3.01%
ASIT.L	Dividend Knight	2023-08-10	Semi-Annually	7	3.14%
USF.L	Dividend Knight	2023-06-15	Quarterly	6	2.80%
MINI.L	No Dividend Player	2023-09-28	Annually	9	0.05%
DAL.L	Dividend Junior	2023-09-14	Sporadic	7	0.47%
SERE.L	Dividend Knight	2023-07-20	Quarterly	9	4.00%
IBT.L	Dividend Knight	2023-07-27	Semi-Annually	30	2.11%
BHP.L	Dividend King	2023-09-07	Semi-Annually	27	5.58%
XPD.L	Dividend Knight	2023-07-07	Semi-Annually	8	2.97%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.189	1.500	6.22	9.33	[0 - 0.5]
returnOnAssetsTTM	0.148	1.200	5.08	6.10	[0 - 0.3]
returnOnEquityTTM	0.245	1.500	8.39	10.00	[0.1 - 1]
payoutRatioTTM	0.669	-1.000	3.31	-3.31	[0 - 1]
currentRatioTTM	1.210	0.800	8.95	7.16	[1 - 3]
quickRatioTTM	0.649	0.800	-0.887	-0.709	[0.8 - 2.5]
cashRatioTTM	0.649	1.500	7.50	10.00	[0.2 - 2]
debtRatioTTM	0.0194	-1.500	9.68	-10.00	[0 - 0.6]
interestCoverageTTM	52.25	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.722	2.00	9.76	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.611	2.00	9.69	10.00	[0 - 20]
debtEquityRatioTTM	0.0306	-1.500	9.88	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.926	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.158	1.000	8.84	8.84	[0.1 - 0.6]
cashFlowToDebtRatioTTM	10.59	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.780	0.800	8.13	6.51	[0.5 - 2]
Total Score				12.95

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	37.07	1.000	6.36	0	[1 - 100]
returnOnEquityTTM	0.245	2.50	8.97	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.611	2.00	9.80	10.00	[0 - 30]
dividendYielPercentageTTM	2.21	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.722	2.00	9.76	10.00	[0 - 30]
payoutRatioTTM	0.669	1.500	3.31	-3.31	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.263	1.000	5.91	0	[0.1 - 0.5]
Total Score				5.22

EMIS Group PLC

EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web, which enables patients to order repeat medication online and track progress from order to home delivery; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.